Description
Mechanism of Action
CJC-1295 mimics GHRH by:
- Stimulating the pituitary gland to release growth hormone
- Increasing GH pulse amplitude and duration
- Promoting downstream IGF-1 secretion from the liver
- Exhibiting extended half-life through DAC (Drug Affinity Complex) modification, enabling longer-lasting effects compared to traditional GHRH peptides
Potential Side Effects / Considerations
- Water retention or mild edema
- Tingling or numbness in extremities (due to GH increase)
- Temporary lethargy or fatigue
- Possible interaction with blood sugar regulation
- Not advised for individuals with active cancer or hormone-sensitive conditions
Note: Effects are based on early clinical research and off-label use. These benefits are not approved claims.
Reviews
There are no reviews yet.